Internal Medicine, Infectious Disease · Norfolk, VA
NPI
1194921783
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
850 Kempsville Rd, Ste 100f
Norfolk, VA, 23502
Phone (757) 261-5910
Groups this clinician bills Medicare through
Medicare paid, 2024
$79K
930 services
Medicare patients, 2024
313
Average age 75
Drug cost, 2024
$1.1M
848 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tariq Iqbal was code 99232 (hospital e&m - subsequent), 390 times for 180 patients. In total Tariq Iqbal billed 930 services in 10 codes, and Medicare paid $79K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 390 | 180 | $63.07 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 161 | 102 | $94.00 | $15K |
| 99223 Hospital E&M - Initial | Facility | 158 | 149 | $136.62 | $22K |
| 99222 Hospital E&M - Initial | Facility | 144 | 135 | $102.60 | $15K |
| 99213 Office E&M - Established | Office | 48 | 34 | $42.87 | $2,058 |
| 99231 Hospital E&M - Subsequent | Facility | 17 | 13 | $39.73 | $675 |
By year: 2022 $95K for 1,230 services; 2023 $77K for 1,055 services; 2024 $79K for 930 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tariq Iqbal prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 138 prescriptions and refills. In total Tariq Iqbal wrote 848 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 138 | 140 | 17 | $505K |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 66 | 66 | Under 11 | $6,912 |
| Ertapenem Ertapenem Sodium | 54 | 54 | 12 | $27K |
| Vancomycin Hcl Generic | 48 | 48 | Under 11 | $4,538 |
| Meropenem Generic | 43 | 43 | 11 | $5,621 |
| Ceftriaxone Ceftriaxone Sodium | 41 | 41 | 15 | $1,384 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 40 | 40 | Under 11 | $9,535 |
| Daptomycin Generic | 29 | 29 | Under 11 | $54K |
| Cefepime Hcl Generic | 28 | 28 | Under 11 | $4,983 |
| Cefazolin Sodium Generic | 28 | 28 | Under 11 | $1,243 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 24 | 24 | Under 11 | $79K |
| Atazanavir Sulfate Generic | 24 | 30 | Under 11 | $6,561 |
| Descovy Emtricitabine/Tenofov Alafenam | 23 | 23 | Under 11 | $53K |
| Juluca Dolutegravir/Rilpivirine | 20 | 20 | Under 11 | $68K |
| Tivicay Dolutegravir Sodium | 19 | 19 | Under 11 | $46K |
Brand drugs: 296 claims; generic drugs: 552 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Tariq Iqbal were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.